These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 28153778)

  • 1. Accelerating the clinical development of protein-based vaccines for malaria by efficient purification using a four amino acid C-terminal 'C-tag'.
    Jin J; Hjerrild KA; Silk SE; Brown RE; Labbé GM; Marshall JM; Wright KE; Bezemer S; Clemmensen SB; Biswas S; Li Y; El-Turabi A; Douglas AD; Hermans P; Detmers FJ; de Jongh WA; Higgins MK; Ashfield R; Draper SJ
    Int J Parasitol; 2017 Jun; 47(7):435-446. PubMed ID: 28153778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of full-length soluble Plasmodium falciparum RH5 protein vaccine using a Drosophila melanogaster Schneider 2 stable cell line system.
    Hjerrild KA; Jin J; Wright KE; Brown RE; Marshall JM; Labbé GM; Silk SE; Cherry CJ; Clemmensen SB; Jørgensen T; Illingworth JJ; Alanine DG; Milne KH; Ashfield R; de Jongh WA; Douglas AD; Higgins MK; Draper SJ
    Sci Rep; 2016 Jul; 6():30357. PubMed ID: 27457156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-step design of a stable variant of the malaria invasion protein RH5 for use as a vaccine immunogen.
    Campeotto I; Goldenzweig A; Davey J; Barfod L; Marshall JM; Silk SE; Wright KE; Draper SJ; Higgins MK; Fleishman SJ
    Proc Natl Acad Sci U S A; 2017 Jan; 114(5):998-1002. PubMed ID: 28096331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APC-Targeted DNA Vaccination Against Reticulocyte-Binding Protein Homolog 5 Induces
    Bjerkan L; Visweswaran GRR; Gudjonsson A; Labbé GM; Quinkert D; Pattinson DJ; Spång HCL; Draper SJ; Bogen B; Braathen R
    Front Immunol; 2021; 12():720550. PubMed ID: 34733274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Plasmodium falciparum reticulocyte binding protein homologue 5-interacting protein, PfRipr, as a highly conserved blood-stage malaria vaccine candidate.
    Ntege EH; Arisue N; Ito D; Hasegawa T; Palacpac NMQ; Egwang TG; Horii T; Takashima E; Tsuboi T
    Vaccine; 2016 Nov; 34(46):5612-5622. PubMed ID: 27692771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production, quality control, stability, and potency of cGMP-produced
    Jin J; Tarrant RD; Bolam EJ; Angell-Manning P; Soegaard M; Pattinson DJ; Dulal P; Silk SE; Marshall JM; Dabbs RA; Nugent FL; Barrett JR; Hjerrild KA; Poulsen L; Jørgensen T; Brenner T; Baleanu IN; Parracho HM; Tahiri-Alaoui A; Whale G; Moyle S; Payne RO; Minassian AM; Higgins MK; Detmers FJ; Lawrie AM; Douglas AD; Smith R; de Jongh WA; Berrie E; Ashfield R; Draper SJ
    NPJ Vaccines; 2018; 3():32. PubMed ID: 30131879
    [No Abstract]   [Full Text] [Related]  

  • 7. Malaria invasion ligand RH5 and its prime candidacy in blood-stage malaria vaccine design.
    Ord RL; Rodriguez M; Lobo CA
    Hum Vaccin Immunother; 2015; 11(6):1465-73. PubMed ID: 25844685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacterially expressed full-length recombinant Plasmodium falciparum RH5 protein binds erythrocytes and elicits potent strain-transcending parasite-neutralizing antibodies.
    Reddy KS; Pandey AK; Singh H; Sahar T; Emmanuel A; Chitnis CE; Chauhan VS; Gaur D
    Infect Immun; 2014 Jan; 82(1):152-64. PubMed ID: 24126527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic polymorphisms in malaria vaccine candidate Plasmodium falciparum reticulocyte-binding protein homologue-5 among populations in Lagos, Nigeria.
    Ajibaye O; Osuntoki AA; Balogun EO; Olukosi YA; Iwalokun BA; Oyebola KM; Hikosaka K; Watanabe YI; Ebiloma GU; Kita K; Amambua-Ngwa A
    Malar J; 2020 Jan; 19(1):6. PubMed ID: 31906953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extent and Dynamics of Polymorphism in the Malaria Vaccine Candidate
    Ouattara A; Tran TM; Doumbo S; Adams M; Agrawal S; Niangaly A; Nelson-Owens S; Doumtabé D; Tolo Y; Ongoiba A; Takala-Harrison S; Traoré B; Silva JC; Crompton PD; Doumbo OK; Plowe CV
    Am J Trop Med Hyg; 2018 Jul; 99(1):43-50. PubMed ID: 29848401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Antibodies that Slow Erythrocyte Invasion Potentiate Malaria-Neutralizing Antibodies.
    Alanine DGW; Quinkert D; Kumarasingha R; Mehmood S; Donnellan FR; Minkah NK; Dadonaite B; Diouf A; Galaway F; Silk SE; Jamwal A; Marshall JM; Miura K; Foquet L; Elias SC; Labbé GM; Douglas AD; Jin J; Payne RO; Illingworth JJ; Pattinson DJ; Pulido D; Williams BG; de Jongh WA; Wright GJ; Kappe SHI; Robinson CV; Long CA; Crabb BS; Gilson PR; Higgins MK; Draper SJ
    Cell; 2019 Jun; 178(1):216-228.e21. PubMed ID: 31204103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naturally acquired antibodies specific for Plasmodium falciparum reticulocyte-binding protein homologue 5 inhibit parasite growth and predict protection from malaria.
    Tran TM; Ongoiba A; Coursen J; Crosnier C; Diouf A; Huang CY; Li S; Doumbo S; Doumtabe D; Kone Y; Bathily A; Dia S; Niangaly M; Dara C; Sangala J; Miller LH; Doumbo OK; Kayentao K; Long CA; Miura K; Wright GJ; Traore B; Crompton PD
    J Infect Dis; 2014 Mar; 209(5):789-98. PubMed ID: 24133188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Production and molecular characterization of Plasmodium falciparum recombinant circumsporozoite protein with 37 NANP and 4 NVDP epitopes].
    Uyar Y; Akşit A; Karaca S; Ceylan ŞS; Yürük M
    Mikrobiyol Bul; 2017 Jan; 51(1):41-51. PubMed ID: 28283009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P113 is a merozoite surface protein that binds the N terminus of Plasmodium falciparum RH5.
    Galaway F; Drought LG; Fala M; Cross N; Kemp AC; Rayner JC; Wright GJ
    Nat Commun; 2017 Feb; 8():14333. PubMed ID: 28186186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional Comparison of Blood-Stage
    Illingworth JJ; Alanine DG; Brown R; Marshall JM; Bartlett HE; Silk SE; Labbé GM; Quinkert D; Cho JS; Wendler JP; Pattinson DJ; Barfod L; Douglas AD; Shea MW; Wright KE; de Cassan SC; Higgins MK; Draper SJ
    Front Immunol; 2019; 10():1254. PubMed ID: 31214195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and Immune Assessment of T Cell Epitopes in Five
    Kotraiah V; Phares TW; Terry FE; Hindocha P; Silk SE; Nielsen CM; Moise L; Tucker KD; Ashfield R; Martin WD; De Groot AS; Draper SJ; Gutierrez GM; Noe AR
    Front Immunol; 2021; 12():690348. PubMed ID: 34305923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterially expressed and refolded receptor binding domain of Plasmodium falciparum EBA-175 elicits invasion inhibitory antibodies.
    Pandey KC; Singh S; Pattnaik P; Pillai CR; Pillai U; Lynn A; Jain SK; Chitnis CE
    Mol Biochem Parasitol; 2002 Aug; 123(1):23-33. PubMed ID: 12165386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The march toward malaria vaccines.
    Hoffman SL; Vekemans J; Richie TL; Duffy PE
    Vaccine; 2015 Nov; 33 Suppl 4(Suppl 4):D13-23. PubMed ID: 26324116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression, Purification and Characterization of GMZ2'.10C, a Complex Disulphide-Bonded Fusion Protein Vaccine Candidate against the Asexual and Sexual Life-Stages of the Malaria-Causing Plasmodium falciparum Parasite.
    Mistarz UH; Singh SK; Nguyen TTTN; Roeffen W; Yang F; Lissau C; Madsen SM; Vrang A; Tiendrebeogo RW; Kana IH; Sauerwein RW; Theisen M; Rand KD
    Pharm Res; 2017 Sep; 34(9):1970-1983. PubMed ID: 28646324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KILchip v1.0: A Novel
    Kamuyu G; Tuju J; Kimathi R; Mwai K; Mburu J; Kibinge N; Chong Kwan M; Hawkings S; Yaa R; Chepsat E; Njunge JM; Chege T; Guleid F; Rosenkranz M; Kariuki CK; Frank R; Kinyanjui SM; Murungi LM; Bejon P; Färnert A; Tetteh KKA; Beeson JG; Conway DJ; Marsh K; Rayner JC; Osier FHA
    Front Immunol; 2018; 9():2866. PubMed ID: 30619257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.